Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jardine Botanical (officially Jardine Botanical SDN BHD) is a Malaysian biotechnology company specializing in the research, development, and production of standardized botanical extracts for the pharmaceutical, nutraceutical, and cosmetic industries. The company is recognized as a key player in the global Salacia market, producing high-potency extracts from Salacia oblonga and Salacia reticulata that target alpha-glucosidase for the management of type 2 diabetes and obesity. Jardine Botanical employs advanced extraction technologies, such as supercritical fluid and solvent-free processes, to ensure the purity and therapeutic consistency of its bioactive compounds. Beyond its role as an ingredient supplier, the company operates a consumer-facing personal care brand called Mysá and engages in strategic international partnerships to expand its footprint in the integrative healthcare and cosmetics sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jardine Botanical.